Works matching IS 09509232 AND DT 2014 AND VI 33 AND IP 42

Results: 9

SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.

Published in:

Oncogene, 2014, v. 33, n. 42, p. 5006, doi. 10.1038/onc.2013.443

By:

Trautmann, M;
Sievers, E;
Aretz, S;
Kindler, D;
Michels, S;
Friedrichs, N;
Renner, M;
Kirfel, J;
Steiner, S;
Huss, S;
Koch, A;
Penzel, R;
Larsson, O;
Kawai, A;
Tanaka, S;
Sonobe, H;
Waha, A;
Schirmacher, P;
Mechtersheimer, G;
Wardelmann, E

Publication type:

Article

Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivo.

Published in:

Oncogene, 2014, v. 33, n. 42, p. 5047, doi. 10.1038/onc.2013.458

By:

Xu, C;
Lin, L;
Cao, G;
Chen, Q;
Shou, P;
Huang, Y;
Han, Y;
Wang, Y;
Shi, Y

Publication type:

Article

p73 regulates serine biosynthesis in cancer.

Published in:

Oncogene, 2014, v. 33, n. 42, p. 5039, doi. 10.1038/onc.2013.456

By:

Amelio, I;
Markert, E K;
Rufini, A;
Antonov, A V;
Sayan, B S;
Tucci, P;
Agostini, M;
Mineo, T C;
Levine, A J;
Melino, G

Publication type:

Article

MicroRNAs and cancer stem cells: the sword and the shield.

Published in:

Oncogene, 2014, v. 33, n. 42, p. 4967, doi. 10.1038/onc.2013.492

By:

Sun, X;
Jiao, X;
Pestell, T G;
Fan, C;
Qin, S;
Mirabelli, E;
Ren, H;
Pestell, R G

Publication type:

Article

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.

Published in:

Oncogene, 2014, v. 33, n. 42, p. 4978, doi. 10.1038/onc.2013.446

By:

Liu, T;
Wang, N;
Cao, J;
Sofiadis, A;
Dinets, A;
Zedenius, J;
Larsson, C;
Xu, D

Publication type:

Article

GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.

Published in:

Oncogene, 2014, v. 33, n. 42, p. 4997, doi. 10.1038/onc.2013.437

By:

Chen, W-T;
Zhu, G;
Pfaffenbach, K;
Kanel, G;
Stiles, B;
Lee, A S

Publication type:

Article

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Published in:

Oncogene, 2014, v. 33, n. 42, p. 5028, doi. 10.1038/onc.2014.108

By:

Sato, T;
Goyama, S;
Kataoka, K;
Nasu, R;
Tsuruta-Kishino, T;
Kagoya, Y;
Nukina, A;
Kumagai, K;
Kubota, N;
Nakagawa, M;
Arai, S;
Yoshimi, A;
Honda, H;
Kadowaki, T;
Kurokawa, M

Publication type:

Article

MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.

Published in:

Oncogene, 2014, v. 33, n. 42, p. 5017, doi. 10.1038/onc.2013.448

By:

Yu, T;
Liu, K;
Wu, Y;
Fan, J;
Chen, J;
Li, C;
Yang, Q;
Wang, Z

Publication type:

Article

Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer.

Published in:

Oncogene, 2014, v. 33, n. 42, p. 4985, doi. 10.1038/onc.2013.444

By:

Zheng, X Q;
Guo, J P;
Yang, H;
Kanai, M;
He, L L;
Li, Y Y;
Koomen, J M;
Minton, S;
Gao, M;
Ren, X B;
Coppola, D;
Cheng, J Q

Publication type:

Article